Plasma lipid peroxidation in sporadic Parkinson's disease. Role of the L-dopa

Journal of the Neurological Sciences

Volumn 240, Issue 1-2, 2006, Pages 31-36

  Agil, Ahmad ^a   Durán, Raquel ^b   Barrero, Francisco ^c   Morales, Blas ^c   Araúzo, Mariano ^c   Alba, Francisco ^d   Miranda, Ma Teresa ^b   Prieto, Isabel ^e   Ramírez, Manuel ^e   Vives, Francisco ^b  

^a Department of Pharmacology   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

^c HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^d Institute of Neurosciences   (Spain)

^e UNIVERSITY OF JAÉN   (Spain)

Author keywords

Catecholamines; L dopa; Lipid peroxidation; Oxidative stress; Parkinson's disease

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; ADRENALIN; AMITRIPTYLINE; BROMOCRIPTINE; CATECHOLAMINE; DOPAMINE; ENTACAPONE; FERROUS ION; HOMOVANILLIC ACID; HYDROGEN PEROXIDE; LEVODOPA; LISURIDE; MANDELIC ACID DERIVATIVE; MAPROTILINE; NORADRENALIN; NORTRIPTYLINE; PERGOLIDE; PRAMIPEXOLE; ROPINIROLE; SELEGILINE;

ARTICLE; CATECHOLAMINE URINE LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; SPECTROFLUOROMETRY; STATISTICAL ANALYSIS;

ANALYSIS OF VARIANCE; ANTIPARKINSON AGENTS; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROCHEMISTRY; HUMANS; LEVODOPA; LINEAR MODELS; LIPID PEROXIDATION; NEUROTRANSMITTER AGENTS; OXIDATIVE STRESS; PARKINSON DISEASE; PLASMA; SPECTROMETRY, FLUORESCENCE;

EID: 29144508700     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2005.08.016     Document Type: Article

References (33)

1. H. Plachta, E. Bartnikowska, and A. Obara Lipid peroxides in blood from patients with atherosclerosis of coronary and peripheral arteries Clin Chim Acta 211 1992 101 112
2. S. Haffner, A. Agil, H. Miettinen, M. Stern, and I. Jialal Plasma oxidizability in subjects with normal glucose tolerance, impaired glucose, tolerance and NIDMM Diabetes Care 18 1995 646 653
3. C. Martinez-Ballesteros, E. Pita-Calandre, Y. Sanchez-Gonzalez, C.M. Rodriguez-Lopez, and A. Agil Lipid peroxidation in adult epileptic patients treated with valproic acid Rev Neurol 38 2004 101 106
4. A. Agil, M. Miro, J. Jimenez, J. Aneiros, M.D. Caracuel, and A. Garcia-Granados Isolation of ani-hepatotoxic principle form the juice of Ecballium elaterium Planta Med 65 1999 673 675
5. H. Sundstrom, H. Korpela, L. Viinikka, and A. Kauppila Serum selenium and glutation peroxidase, and plasma lipid peroxides in uterine, ovarian or vulvar cancer, and their responses to antioxidants in patients with ovarian cancer Cancer Lett 24 1984 1 10
6. P. Jenner, and C.W. Olanow Oxidative stress and the pathogenesis of Parkinson's disease Neurology 47 1996 S161 S170
7. H. Khaldy, G. Escames, J. Leon, F. Vives, J.D. Luna, and D. Acuna-Castroviejo Comparative effects of melatonin l-deprenyl, trolox and ascorbate in the suppression of hydroxyl radical formation during dopamine autoxidation in vitro J Pineal Res 29 2000 100 107
8. G. Cohen Oxygen radicals and Parkinson's disease Proceedings of Upjohn symposium 1987 Fed amer soc exp biol Bethesda, MD 130 135
9. A. Agil, C.J. Fuller, and I. Jialal Susceptibility of plasma to ferrous iron/hydrogen peroxide-mediated oxidation: demonstration of a possible Fenton reaction Clin Chem 41 1995 220 225
10. M.B. Youdim, D. Ben-Shachar, and P. Riederer The possible role of iron in the etiopathology of Parkinson's disease Mov Disord 8 1993 1 12
11. M.B. Youdim, and P. Riederer Understanding Parkinson's disease Sci Am 276 1997 52 59
12. T.V. Ilic, M. Jovanovic, A. Jovicic, and M. Tomovic Oxidative stress indicators are elevated in the novo Parkinson's disease patients Func Neurol 14 1999 141 147
13. J.A. Serra, R.O. Dominguez, E.S. de Lustig, E.M. Guareschi, A.L. Famulari, and E.L. Bartolome Parkinson's disease is associated with oxidative stress: comparison of peripheral antioxidant profiles in living Parkinson's Alzheimer's and vascular dementia patients J Neurol Transm 108 2001 1135 1148
14. J.E. Ahlskog, R.J. Uitti, P.A. Lw, G.M. Tyce, K.K. Nickander, and R.C. Petersen No evidence for systemic oxidant stress in Parkinson's or Alzheimer's disease Mov Disord 10 1995 566 573
15. M.P. Montilla, A. Agil, M.C. Navarro, M.I. Jimenez, A. Garcia-Granados, and A. Parra Antioxidant activity of maslinic acid, a triterpene derivative obtained from Olea europaea Planta Med 69 2003 472 474
16. C. Mytilineou, S.K. Han, and G. Cohen Toxic and protective effects of l-DOPA on mesencephalic cell cultures J Neurochem 61 1993 1470 1478
17. E. Martignoni, F. Blandini, L. Godi, S. Desideri, C. Pacchetti, and F. Mancini Peripheral markers of oxidative stress in Parkinson's disease. The role of l-DOPA Free Radic Biol Med 27 1999 428 437
18. M. Sohmiya, M. Tanaka, N. Wei Tak, M. Yanagisawa, Y. Tanino, and Y. Suzuki Redox status of plasma coenzyme Q10 indicates elevated systemic oxidative stress in Parkinson's disease J Neurol Sci 223 2004 161 166
19. Y. Ihara, M. Chuda, S. Kuroda, and T. Hayabara Hydroxyl radical and superoxide dismutase in blood of patients with Parkinson's disease: relationship to clinical data J Neurol Sci 170 1999 90 95
20. D.J. Gelb, E. Oliver, and S. Gliman Diagnostic criteria for Parkinson disease Arch Neurol 56 1999 33 39
21. M.M. Hoehn, and M.D. Yahr Parkinsonism: onset, progression and mortality Neurology 17 1967 427 442
22. S. Fahn, and R.L. Elton Unified Parkinson's disease rating scale S. Fahn C.D. Marsden D. Calne M. Goldstein Recent developments in Parkinson's disease vol 2 1987 Macmillan Florham Park, NJ 153 163
23. K. Yagi Assay for blood plasma or serum Methods Enzymol 105 1984 328 331
24. C. Buhmann, S. Arlt, A. Kontush, T. Moller-Bertram, S. Sperber, and M. Oechsner Plasma and CSF markers of oxidative stress are increased in Parkinson's disease and influenced by antiparkinsonian medication Neurobiol Dis 15 2004 160 170
25. A. Agil, and S.M. Sadrzadeh Hydroxy-urea protects erythrocytes against oxidative damage Redox Rep 5 2000 29 34
26. S.T. Omaye, J.D. Turnbull, and H.E. Sauberlich Selected methods for the determination of ascorbic acid in animal cells, tissues and fluids Methods Enzymol 62 1979 3 11
27. N.K. Menon, J.V. Furdik, and K. Mishra Role of oxygen free radicals in neurological disorders Adv Clin Neurosci 4 1994 327 339
28. P. Jenner, D.T. Dexter, J. Sian, A.H. Schapira, and C.D. Marsden Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The royal kings and queens Parkinson's disease research group Ann Neurol 32 1992 S82 S87
29. P. Jenner, A.H. Schapira, and C.D. Marsden New insights into the cause of Parkinson's disease Neurology 42 1992 2241 2250
30. F. Marzatico, C. Café, M. Taborelli, and G. Benzi Experimental Parkinson's disease in monkeys. Effect of ergot alkaloid derivative on lipid peroxidation in different brain areas Neurochem Res 18 1993 1101 1106
31. C.W. Olanow The scientific basis for the current treatment of Parkinson's disease Annu Rev Med 55 2004 41 60
32. G. Scigliano, M. Musicco, P. Soliveri, F. Girotti, P. Giovannini, and V. Fetoni Increased plasma bilirubin in Parkinson patients on l-dopa: evidence against the free radical hypothesis? Ital J Neurol Sci 18 2 1997 69 72
33. B. Frei, R. Stoker, and B.N. Ames Antioxidant defenses and lipid peroxidation in human blood plasma Proc Natl Acad Sci U S A 85 1988 9748 9752